Tag: Audentes Therapeutics

Astellas hit by fatal event in ASPIRO clinical trial of AT132 in XLMTM

businessnewstoday- September 14, 2021 0

Astellas Pharma said that a participant in the ASPIRO clinical trial of AT132, who had developed a serious adverse event earlier this month, has passed away. The ... Read More

Astellas Pharma to acquire US gene therapy company Audentes Therapeutics

pharmanewsdaily- December 8, 2019 0

Astellas acquisition of Audentes: Japanese pharma company Astellas Pharma has agreed to acquire US gene therapy company Audentes Therapeutics in an all-cash deal worth about ... Read More